Cargando…

Adherence to National Comprehensive Cancer Network ALK Testing Guidelines for Patients with Advanced Non‐Small Cell Lung Cancer in U.S. Community Medical Centers

BACKGROUND: National Comprehensive Cancer Network (NCCN) guidelines recommend biomarker testing as the first step in the management of patients with advanced non‐small cell lung cancer (aNSCLC). We assessed anaplastic lymphoma kinase (ALK) testing rates and factors related to underuse in community m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bernicker, Eric H., Xiao, Yan, Abraham, Anup, Yang, Baiyu, Croix, Denise A., Redpath, Stella, Engstrom‐Melnyk, Julia, Shah, Roma, Madala, Jaya, Allen, Timothy C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2021
Materias:	Lung Cancer
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176985/ https://www.ncbi.nlm.nih.gov/pubmed/33823082 http://dx.doi.org/10.1002/onco.13779

Ejemplares similares

Anaplastic lymphoma kinase rearrangement prevalence in patients with advanced non-small cell lung cancer in the United States: retrospective real world data
por: Allen, Timothy Craig, et al.
Publicado: (2021)

ALK Inhibitors or Chemotherapy for Third Line in ALK-positive NSCLC? Real-world Data
por: Moskovitz, Mor, et al.
Publicado: (2022)

Real-World Efficacy and Tolerability of Brigatinib in Patients with Non-Small Cell Lung Cancer with Prior ALK-TKIs in the United States
por: Jahanzeb, Mohammad, et al.
Publicado: (2022)

Arterial and Venous Thromboembolism in ALK-Rearrangement-Positive Non-small Cell Lung Cancer: A Population-Based Cohort Study
por: Icht, Oded, et al.
Publicado: (2023)

Differential eligibility of African American and European American lung cancer cases using LDCT screening guidelines
por: Ryan, Bríd M
Publicado: (2016)

Value of Precision Medicine in Advanced Non‐Small Cell Lung Cancer: Real‐World Outcomes Associated with the Use of Companion Diagnostics
por: John, Ani, et al.
Publicado: (2020)

Adhering to guideline concordant care improves survival among the different subtypes of T3 N2 non–small cell lung cancer
por: Wang, Jennifer C., et al.
Publicado: (2022)

Factors influencing the utilization of prophylactic cranial irradiation in patients with limited-stage small cell lung cancer
por: Lok, Benjamin H., et al.
Publicado: (2017)

LDCT lung cancer screening in populations at different risk for lung cancer
por: Teles, Gustavo Borges da Silva, et al.
Publicado: (2020)

Geographical variations in the use of cancer treatments are associated with survival of lung cancer patients
por: Møller, Henrik, et al.
Publicado: (2018)

Internal dose escalation is associated with increased local control for non-small cell lung cancer (NSCLC) brain metastases treated with stereotactic radiosurgery (SRS)
por: Abraham, Christopher, et al.
Publicado: (2017)

CATCHING COVID-19 HIDDEN IN THE CANCER
por: Otero, Rafael, et al.
Publicado: (2020)

Lung cancer specialists' opinions on treatment for stage I non-small cell lung cancer: A multidisciplinary survey
por: Lammers, Austin, et al.
Publicado: (2018)

Incidence of second and higher order smoking-related primary cancers following lung cancer: a population-based cohort study
por: Barclay, Matthew E, et al.
Publicado: (2019)

Management of Lung Cancer in the Patient with Interstitial Lung Disease
por: Frank, Angela J, et al.
Publicado: (2022)

UK Lung Cancer RCT Pilot Screening Trial: baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening
por: Field, J K, et al.
Publicado: (2016)

Analysis of lung cancer risk model (PLCO(M2012) and LLP(v2)) performance in a community-based lung cancer screening programme
por: Lebrett, Mikey B, et al.
Publicado: (2020)

Prevalence and outcome of central airway obstruction in patients with lung cancer
por: Daneshvar, Cyrus, et al.
Publicado: (2019)

Physical Activity and Exercise in Lung Cancer Care: Will Promises Be Fulfilled?
por: Avancini, Alice, et al.
Publicado: (2019)

Evaluation of cardiovascular risk in a lung cancer screening cohort
por: Ruparel, Mamta, et al.
Publicado: (2019)

Responding to symptoms suggestive of lung cancer: a qualitative interview study
por: Birt, Linda, et al.
Publicado: (2014)

Diffuse Alveolar Hemorrhage in a Patient Receiving Bevacizumab for Lung Cancer
por: Sethi, Sakshi, et al.
Publicado: (2014)

Validation of Progression‐Free Survival as a Surrogate Endpoint for Overall Survival in Malignant Mesothelioma: Analysis of Cancer and Leukemia Group B and North Central Cancer Treatment Group (Alliance) Trials
por: Wang, Xiaofei, et al.
Publicado: (2017)

Cell migration leads to spatially distinct but clonally related airway cancer precursors
por: Pipinikas, Christodoulos P, et al.
Publicado: (2014)

Image enhancement technology in bronchoscopy: a prospective multicentre study in lung cancer
por: van der Heijden, Erik H F M, et al.
Publicado: (2018)

Retrospect and Prospect for Lung Cancer in China: Clinical Advances of Immune Checkpoint Inhibitors
por: Lu, Shun, et al.
Publicado: (2019)

Defining the information needs of lung cancer screening participants: a qualitative study
por: Ruparel, Mamta, et al.
Publicado: (2019)

IMPACT OF COVID-19 PANDEMIC ON DIAGNOSIS AND TREATMENT OF LUNG CANCER IN THE VETERAN COHORT
por: ABBAS, HATOON, et al.
Publicado: (2021)

Stage I and II Small-Cell Lung Cancer—New Challenge for Surgery
por: Doerr, Fabian, et al.
Publicado: (2022)

Management of venous thromboembolism in patients with lung cancer: a state-of-the-art review
por: Xiong, Wei, et al.
Publicado: (2023)

Uptake of minimally invasive surgery and stereotactic body radiation therapy for early stage non-small cell lung cancer in the USA: an ecological study of secular trends using the National Cancer Database
por: Blom, Erik F, et al.
Publicado: (2020)

ERK and AKT phosphorylation status in lung cancer and emphysema using nanocapillary isoelectric focusing
por: Crosbie, Philip A J, et al.
Publicado: (2016)

Integrated care for resected early stage lung cancer: innovations and exploring patient needs
por: Ho, Jan, et al.
Publicado: (2017)

Household disposable income and long-term survival after pulmonary resections for lung cancer
por: Sachs, Erik, et al.
Publicado: (2020)

Feasibility and acceptability of a community pharmacy referral service for suspected lung cancer symptoms
por: Holland-Hart, Daniella, et al.
Publicado: (2021)

Optimal resection rate for lung cancer in the UK: how high should we go?
por: Belcher, Elizabeth, et al.
Publicado: (2021)

Hospital-based multidisciplinary lung cancer care in Australia: a survey of the landscape in 2021
por: Brims, Fraser J H, et al.
Publicado: (2022)

COVID-19 VACCINATION-ASSOCIATED LYMPHADENOPATHY: A DIAGNOSTIC CONUNDRUM IN LUNG CANCER STAGING
por: ELSHAKH, HADYA, et al.
Publicado: (2022)

RET Fusion-Positive Non-small Cell Lung Cancer: The Evolving Treatment Landscape
por: Novello, Silvia, et al.
Publicado: (2023)

Survival of patients with small cell lung cancer undergoing lung resection in England, 1998–2009
por: Lüchtenborg, Margreet, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_8tua2a7jnq33k0l5o8m8pt88jc